- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
George Koroneos
George Koroneos
News & Online Content Editor
gkoroneos@advanstar.com
George Koroneos oversees news content for Pharmaceutical Executive Magazine as well as two e-newsletters, Pharm Exec Direct and Pharm Exec Direct Marketing Edition. Prior to joining the team, George worked for Pharm Exec's sister publication Pharmaceutical Technology, as well as a number of trade magazines and newspapers. A self proclaimed tech geek, George is on the cutting edge of most social media trends and spends most of his time juggling his blog, Twitter, and Facebook accounts. In his spare time, he is an accomplished event and portrait photographer.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
